Activation of C5aR1 by its ligand C5a amplifies inflammation through crosstalk with TLR signaling, leading to enhanced NF-κB activation, cytokine release, and endothelial dysfunction [41,42]. The gene discussed is NFKB1; the disease is endothelial dysfunction.